Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,602,281 papers from all fields of science
Search
Sign In
Create Free Account
AB103
Known as:
AB103 peptide
, SPMLVAYD
, p2TA peptide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
CD28 Antigens
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Interventions for necrotizing soft tissue infections in adults.
C. Hua
,
R. Bosc
,
+5 authors
L. Le Cleach
The Cochrane database of systematic reviews
2018
Corpus ID: 205209753
BACKGROUND Necrotizing soft tissue infections (NSTIs) are severe and rapidly spreading soft tissue infections of the subcutaneous…
Expand
2015
2015
Excess of Rare Variants in Genes that are Key Epigenetic Regulators of Spermatogenesis in the Patients with Non-Obstructive Azoospermia
Zesong Li
,
Yi Huang
,
+29 authors
Yaoting Gui
Scientific reports
2015
Corpus ID: 11786962
Non-obstructive azoospermia (NOA), a severe form of male infertility, is often suspected to be linked to currently undefined…
Expand
2015
2015
CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitis.
G. Ramachandran
,
R. Kaempfer
,
+13 authors
S. Opal
The Journal of infectious diseases
2015
Corpus ID: 16699953
BACKGROUND Severe gram-negative bacterial infections and sepsis are major causes of morbidity and mortality. Dysregulated…
Expand
Highly Cited
2014
Highly Cited
2014
A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial.
E. Bulger
,
R. Maier
,
+14 authors
A. Shirvan
JAMA surgery
2014
Corpus ID: 11477088
IMPORTANCE Necrotizing soft-tissue infections (NSTI) have high morbidity and mortality rates despite aggressive surgical…
Expand
2014
2014
Single Administration of p2TA (AB103), a CD28 Antagonist Peptide, Prevents Inflammatory and Thrombotic Reactions and Protects against Gastrointestinal Injury in Total-Body Irradiated Mice
S. Mirzoeva
,
T. Paunesku
,
+4 authors
W. Small
PloS one
2014
Corpus ID: 12097559
The goal of this study was to elucidate the action of the CD28 mimetic peptide p2TA (AB103) that attenuates an excessive…
Expand
2014
2014
Treatment for Necrotizing Soft-Tissue Infections: More Skin in the Game.
R. Sawyer
JAMA surgery
2014
Corpus ID: 32175265
Thearticle byBulger et al1 represents an advance in theworld of surgical infections as the first interventional trial using an…
Expand
Review
2014
Review
2014
AB103. Prostatectomy versus active surveillance for early stage prostate cancer: a meta-analysis
You Luo
,
Shengjun Fu
,
Li Yang
Translational Andrology and Urology
2014
Corpus ID: 36865984
Objective To compare the survival effect between radical prostatectomy (RP) and active surveillance (AS) for the treatment of…
Expand
2013
2013
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
G. Ramachandran
,
M. Tulapurkar
,
+8 authors
A. Cross
The Journal of infectious diseases
2013
Corpus ID: 14865321
Staphylococcus aureus and group A Streptococcus pyogenes (GAS) express superantigen (SAg) exotoxin proteins capable of inducing…
Expand
2011
2011
AB103, a CD28 antagonist peptide: a new therapeutic agent in a model of severe sepsis
D. Teleman
,
C. Chung
,
A. Ayala
,
S. Opal
,
A. Chahin
,
A. Shirvan
Critical Care
2011
Corpus ID: 52836538
AB103 is a novel CD28 antagonist peptide currently in clinical development that modulates CD28 signaling in T cells, without…
Expand
1990
1990
A mathematical description of recombinant yeast
S. Coppella
,
P. Dhurjati
Biotechnology and bioengineering
1990
Corpus ID: 24087907
A model was formulated to examine specific experimental data of growth and heterologous product formation with recombinant…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE